Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.

@article{Matsuda2017LowDoseMF,
  title={Low-Dose Morphine for Dyspnea in Terminally Ill Patients with Idiopathic Interstitial Pneumonias.},
  author={Yoshinobu Matsuda and Isseki Maeda and Kazunobu Tachibana and Keiko Nakao and Yumiko Sasaki and Chikatoshi Sugimoto and Toru Arai and Akihiro Tokoro and Masanori Akira and Yoshikazu Inoue},
  journal={Journal of palliative medicine},
  year={2017},
  volume={20 8},
  pages={879-883}
}
BACKGROUND Dyspnea is highly prevalent in patients with idiopathic interstitial pneumonias (IIPs). OBJECTIVE The objective of this study is to examine the effectiveness and safety of continuous subcutaneous morphine for dyspnea in terminally ill IIP patients. SETTING/SUBJECTS We retrospectively reviewed cases of terminally ill IIP patients who received… CONTINUE READING